ArticleThe American journal of case reports2026
Pulsed Radiofrequency of the Sacral Dorsal Root Ganglia as a Potential Rescue Therapy for Refractory Chronic Pelvic Pain: A Case Series.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Chronic pelvic pain (CPP) is a prevalent, multifactorial condition with neuropathic, visceral, myofascial, and psychogenic components; a subset of patients remain refractory to multimodal pharmacotherapy and conventional interventional procedures. Pulsed radiofrequency (PRF) of the dorsal root ganglia (DRG) is a minimally invasive neuromodulatory technique that can attenuate pathological nociceptive transmission while preserving neural integrity. We describe 3 patients with severe, treatment-refractory CPP of predominantly neuropathic origin who underwent sacral DRG PRF as rescue therapy. CASE REPORT Case 1 was a 46-year-old man with a 7-year history of neuropathic penile pain following circumcision. Case 2 was a 54-year-old woman with an 11-year history of urethral burning pain and urgency after anal sphincterotomy. Case 3 was a 39-year-old woman with an 18-year history of CPP related to interstitial cystitis, vulvodynia, and pelvic floor myofascial dysfunction. All 3 had failed extensive pharmacological, nerve block, and neuromodulation therapies. Bilateral PRF of the S2-S4 DRG produced reductions in pain intensity (Numeric Rating Scale, NRS) of 55.6-62.5% at 3 months, partially sustained at 6 months (42.9-50.0%), with parallel improvements in neuropathic pain scores, quality of life, and reduced analgesic use, without procedure-related complications. CONCLUSIONS In these 3 refractory CPP cases, sacral DRG PRF was associated with clinically meaningful, although partially attenuating, symptomatic improvement. Given the small, uncontrolled sample, these findings represent preliminary clinical observations suggesting possible benefit in carefully selected patients and should be regarded as hypothesis-generating rather than evidence of established clinical effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.